Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review
- PMID: 38455223
- PMCID: PMC10916574
- DOI: 10.1002/fsn3.3869
Therapeutic potential of mangiferin in cancer: Unveiling regulatory pathways, mechanisms of action, and bioavailability enhancements - An updated review
Abstract
Mangiferin (MGF) is a phenolic compound, which is a major source of MGF is the mango tree. MGF possesses some antioxidant, anti-inflammatory, and cytoprotective properties, enabling it to play its role against various diseases such as diabetes, obesity, lung injuries, and cancer. The word "Cancer" depicts an uncontrolled and abnormal growth of cells. This review paper reveals MGF's therapeutic, curative and protective potential impact against lung, liver, ovarian, prostate, breast, stomach, and oral cancers. MGF is used in various types of research in the form of powder, liquid extract, intramuscular, intravenous, nanoparticles coated with gold, in the form of a solution, or in combination with other drugs to evaluate synergistic effects. Many studies showed that MGF is safe to use but has less bioavailability in the body and 0.111 mg/mL solubility in water. However, certain studies indicated that its bioavailability and retention time increased when taken in the form of nanoparticles and in combination with other drugs. MGF also increases the sensitivity of other drugs (i.e., cisplatin) resistant to tumors. MGF has different mechanisms of action for different cancers. It mainly targets enzymes, interleukins, tumor growth factors, signaling pathways, apoptotic proteins, and genes to inhibit the growth of tumors, volume, angiogenesis, cellular functionality, further progression, and movement to other areas of the body. Moreover, MGF increases apoptosis and body weight with no or fewer side effects on normal cells. MGF unveiled a novel gate toward the treatment of cancer. Further research and human trials are needed in this regard.
Keywords: angiogenesis; anticancer; antiproliferative; anti‐inflammatory; apoptosis; mangiferin.
© 2023 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
None.
Figures
Similar articles
-
Mangiferin: A natural neuroprotective polyphenol with anti-inflammatory and anti-oxidant properties for depression.Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jun 20;139:111401. doi: 10.1016/j.pnpbp.2025.111401. Epub 2025 May 14. Prog Neuropsychopharmacol Biol Psychiatry. 2025. PMID: 40379124 Review.
-
Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling.Front Pharmacol. 2018 Mar 7;9:201. doi: 10.3389/fphar.2018.00201. eCollection 2018. Front Pharmacol. 2018. PMID: 29563875 Free PMC article.
-
Transferrin-Modified Mangiferin-Loaded SLNs: Preparation, Characterization, and Application in A549 Lung Cancer Cell.Drug Des Devel Ther. 2022 Jun 8;16:1767-1778. doi: 10.2147/DDDT.S366531. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35707686 Free PMC article.
-
Mangiferin alleviates cisplatin-induced ototoxicity in sensorineural hearing loss.Biomed Pharmacother. 2024 Sep;178:117174. doi: 10.1016/j.biopha.2024.117174. Epub 2024 Aug 3. Biomed Pharmacother. 2024. PMID: 39098177
-
Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy.Cancers (Basel). 2023 Aug 21;15(16):4194. doi: 10.3390/cancers15164194. Cancers (Basel). 2023. PMID: 37627222 Free PMC article. Review.
Cited by
-
Polyphenolic protection: the role of mangiferin in mitigating neurodegeneration and neuroinflammation.Inflammopharmacology. 2025 Jul 22. doi: 10.1007/s10787-025-01854-3. Online ahead of print. Inflammopharmacology. 2025. PMID: 40696232 Review.
-
Editorial: Health Implications of Dietary Fibers and Bioactive Carbohydrates From Natural Resources.Food Sci Nutr. 2025 May 6;13(5):e70208. doi: 10.1002/fsn3.70208. eCollection 2025 May. Food Sci Nutr. 2025. PMID: 40336534 Free PMC article. No abstract available.
-
Synthesis of mangiferin derivatives, complexes, and carriers as potential therapeutic candidates for cancer treatment: an update.Front Pharmacol. 2025 Jun 3;16:1598719. doi: 10.3389/fphar.2025.1598719. eCollection 2025. Front Pharmacol. 2025. PMID: 40529503 Free PMC article. Review.
-
Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp.Future Microbiol. 2024 Sep;19(13):1157-1170. doi: 10.1080/17460913.2024.2366627. Epub 2024 Jul 16. Future Microbiol. 2024. PMID: 39012219 Free PMC article.
-
Formulation and evaluation of polymeric nanoparticles to improve in vivo chemotherapeutic efficacy of mangiferin against breast cancer.Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 28. doi: 10.1007/s00210-025-04068-0. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40153014
References
-
- Adoho, A. C. C. , Konmy, B. B. S. , Olounladé, P. A. , Azando, E. V. , Hounzangbé‐Adoté, M. S. , & Gbangboché, B. A. (2022). Phytochemistry and larval toxicity of Ipomea asarifolia, Commelina diffusa, Acalypha ciliata and Eleusine indica against Artemia salina . International Journal of Veterinary Science, 11(2), 121–128.
-
- Akhtar, T. , Shahid, S. , Asghar, A. , Naeem, M. I. , Aziz, S. , & Ameer, T. (2023). Utilisation of herbal bullets against Newcastle disease in poultry sector of Asia and Africa (2012–2022). International Journal of Agriculture and Biosciences, 12(1), 56–65.
-
- AlMasri, S. , Zenati, M. , Hammad, A. , Nassour, I. , Liu, H. , Hogg, M. E. , Zeh, H. J. , Boone, B. , Bahary, N. , Singhi, A. D. , Lee, K. K. , Paniccia, A. , & Zureikat, A. H. (2022). Adaptive dynamic therapy and survivorship for operable pancreatic cancer. JAMA Network Open, 5(6), e2218355. - PMC - PubMed
-
- Balasar, M. , Özkent, M. S. , Aydin, A. , Taskapu, H. H. , Atici, A. , Ecer, G. , & Sonmez, M. G. (2022). The benign renal masses that were exposed after nephron‐sparing surgery: “postsurgical fatty tumor.” Is it related to the surgical technique? Journal of Kidney Cancer and VHL, 9(1), 1. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources